MedTrace Logo

Product Surveillance Registry; Ear, Nose and Throat - EXTEND Cohort

NCT06671561 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-05-15

No results posted yet for this study

Summary

The purpose of this study is to confirm long-term clinical safety and performance, acceptability of identified risks, and detect emerging risks based on factual evidence for the PROPEL family of products when used according to labeling in a real-world setting.

Conditions

  • Chronic Rhinosinusitis (CRS)

Interventions

DEVICE

Observational data collection from patients with chronic rhinosinusitis (CRS) receiving PROPEL sinus implant(s) following functional endoscopic sinus surgery (FESS)

Observational data collection

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-30
Primary Completion
2026-08-31
Completion
2027-04-30
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06671561 on ClinicalTrials.gov